020 7405 4321

Laboratorios Almirall SA -and- Boehringer Ingelheim International GmbH [2009] EWHC 102 (Pat)

Case Summary  |  Judgment  |  23 January 2009


Andrew Lykiardopoulos appeared as junior counsel for the Defendant in this patent revocation dispute heard by His Honour Judge Fysh QC in December 2008. Each party sought a declaration of invalidity in relation to the other's patent. Both patents related to a substance called aclidinium, an anticholinergic used to treat respiratory disorders. The Judge held that both patents were invalid and should be revoked.